Gregory Riely

36PUBLICATIONS
353CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

|Jul 16, 2026
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART).

|Jul 02, 2026
Clinical Validation of Tissue and Liquid Companion Diagnostics for BRAF V600E Detection in Non-Small Cell Lung Cancers from the PHAROS Study.

|Oct 19, 2025
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.

Melissa L Johnson, Egbert F Smit, Enriqueta Felip

|Sep 24, 2025
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas.

Jessica S Ross, Rohit Thummalapalli, Kristine Lacuna

|Jun 16, 2025
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research.

Michal Sternschuss, Michael Lattanzi, Emily Vertosick

Pageof 6

Frequent Collaborators

8 joint publications

Marc Ladanyi

6 joint publications

Natasha Leighl

6 joint publications

Navneet Singh

6 joint publications

Gregory Masters